Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.167647906927093e-74,113.99022633744856,19198.429906252102,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPS11', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.8240532753292744e-71,0,0,76
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.2299166272076686e-52,48.025396825396825,5740.3545841657,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'SLC25A5', 'SLC25A4', 'SLC25A6', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'ATP5MC1', 'COX11', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1D', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.422935755599107e-50,0,0,61
3,Oxidative phosphorylation WP623,3.6808494811095384e-29,36.62388943731491,2397.832848343941,"['NDUFB9', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'NDUFV2', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS3', 'ATP5PO']",4.834182318523861e-27,0,0,35
4,Nonalcoholic fatty liver disease WP4396,3.545230000526647e-27,10.422741909940347,634.7887002217507,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'UQCRFS1', 'COX8A', 'NDUFC2', 'NDUFC1', 'COX6B1', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'NDUFB9', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX5A', 'UQCRH', 'CYC1', 'NDUFV2', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFA1', 'COX6C', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",3.4920515505187475e-25,0,0,51
5,Mitochondrial complex I assembly model OXPHOS system WP4324,7.704491768796212e-25,34.36444007858546,1908.0107521382088,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'NDUFV2', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4', 'NDUFAB1', 'NDUFS3', 'NDUFAF3', 'TMEM126B']",6.071139513811415e-23,0,0,30
6,Mitochondrial CIV Assembly WP4922,2.369843961004641e-15,22.686770428015564,763.9985983477038,"['COX8A', 'COA3', 'COX7B', 'COX16', 'PET100', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'PET117', 'COX6B1', 'COX11', 'COX14', 'SMIM20']",1.5561975343930478e-13,0,0,20
7,Mitochondrial complex III assembly WP4921,2.9669884250117182e-08,33.69008662175168,583.954762434571,"['UQCRB', 'UQCC3', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",1.66999062779231e-06,0,0,9
8,Cellular Proteostasis WP4918,3.0880808375231185e-07,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",1.5208798124801359e-05,0,0,6
9,Proteasome Degradation WP183,2.639044524958398e-05,4.873848631239936,51.382590796488316,"['H2AFZ', 'HLA-B', 'PSMB10', 'PSMA7', 'PSMD8', 'PSMB6', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMA2', 'PSMB1', 'PSME1']",0.0011553150475928987,0,0,13
10,mRNA Processing WP411,5.475264568230076e-05,3.677266255339345,36.08385493742935,"['SF3B5', 'DHX8', 'RNMT', 'SNU13', 'LSM2', 'PRPF4', 'LSM7', 'PHF5A', 'SNRPD1', 'SNRPG', 'SRSF3', 'SNRPE', 'SNRPB2', 'DNAJC8', 'HNRNPA1', 'SRSF9']",0.0021572542398826497,0,0,16
11,Cholesterol Biosynthesis Pathway WP197,0.00018464257364871707,11.194817658349328,96.24283967272031,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK', 'FDFT1']",0.006613561274326775,0,0,6
12,Pyrimidine metabolism WP4022,0.0004158382215782228,3.27857027724049,25.52437208716952,"['POLR3GL', 'NME2', 'NME1', 'POLE4', 'POLD4', 'POLD2', 'POLE3', 'POLR3H', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR3K', 'POLR2K', 'POLR2L']",0.013653354941818317,0,0,14
13,Nucleotide Excision Repair WP4753,0.002346226648518842,4.073076923076923,24.662264581694046,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.07110871534741721,0,0,8
14,Fatty acid transporters WP5061,0.004121584140255306,8.939463601532568,49.09122250209936,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.11389139889647612,0,0,4
15,Glycolysis and Gluconeogenesis WP534,0.004463055231501065,3.5833846153846154,19.392997023915616,"['LDHA', 'TPI1', 'PDHA1', 'GOT1', 'MPC2', 'PGK1', 'DLD', 'PFKM']",0.11389139889647612,0,0,8
16,Dual hijack model of Vif in HIV infection WP3300,0.00491409589147232,16.74976076555024,89.0358237905825,"['ELOB', 'ELOC', 'RBX1']",0.11389139889647612,0,0,3
17,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.00491409589147232,16.74976076555024,89.0358237905825,"['ELOB', 'ELOC', 'RBX1']",0.11389139889647612,0,0,3
18,DNA Mismatch Repair WP531,0.0056076316773009454,5.5901246404602105,28.977119954688344,"['POLE4', 'POLD4', 'POLD2', 'POLE3', 'RPA2']",0.11628457267666172,0,0,5
19,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0056076316773009454,5.5901246404602105,28.977119954688344,"['EIF5', 'EIF3I', 'EIF3J', 'EIF2S1', 'EIF1']",0.11628457267666172,0,0,5
20,Computational Model of Aerobic Glycolysis WP4629,0.006424765213024062,7.448914431673052,37.59910466786742,"['LDHA', 'TPI1', 'PGK1', 'PFKM']",0.12656787469657402,0,0,4
21,Base Excision Repair WP4752,0.0072899427249691826,4.194457773512476,20.642015541278628,"['POLE4', 'POLD4', 'NEIL2', 'APEX1', 'POLD2', 'POLE3']",0.13677321112561228,0,0,6
22,7q11.23 copy number variation syndrome WP4932,0.011280168826506998,2.319198508853681,10.400930578823592,"['ATP5PB', 'CLTC', 'ATP5MC2', 'EIF4H', 'ATP5PO', 'ATP5MC3', 'SQSTM1', 'DLD', 'ATP5F1D', 'VAMP2', 'ATP5F1E', 'ATP5MC1']",0.20201756898380716,0,0,12
23,Selenium Micronutrient Network WP15,0.015077424663535307,2.4346569489821563,10.212306640116019,"['SELENOM', 'PRDX5', 'GPX4', 'PRDX1', 'SELENOW', 'TXN', 'SEPHS2', 'SELENOH', 'SOD1', 'MSRB1']",0.25701650003777465,0,0,10
24,VEGFA-VEGFR2 Signaling Pathway WP3888,0.01647589155097483,1.5284059168790223,6.275416262072839,"['RPL5', 'SET', 'NOTCH4', 'CLTC', 'ARPC5L', 'TXN', 'RPL10A', 'RPL7', 'ACTG1', 'LDHA', 'PSMD4', 'RPL18A', 'CCND1', 'TMSB4X', 'RACK1', 'AP2S1', 'PGK1', 'RPLP2', 'ELOC', 'ATP6V1E1', 'RPS11', 'CCT7', 'TMSB10', 'ACP1', 'HRAS', 'SDF2L1', 'SSR4', 'TPM3', 'RPS6', 'SARS', 'RPL13A', 'CYCS', 'RPL27', 'RPL26', 'PTMA']",0.25701650003777465,0,0,35
25,Ciliary landscape WP4352,0.01657557401984576,1.7826261503304306,7.308455456156227,"['NUDC', 'NDUFA5', 'TRAF3IP1', 'SSNA1', 'COPS7A', 'MYL6B', 'DYNLL1', 'COX6C', 'LSM4', 'PSMD8', 'COPS4', 'MYL6', 'COPS6', 'IFT22', 'PSMD7', 'RAB14', 'NEFL', 'SNRPB2', 'DCAF11', 'CALM2']",0.25701650003777465,0,0,20
26,Ferroptosis WP4313,0.016960479697924215,3.354414587332054,13.675510068410782,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'VDAC2', 'FTL']",0.25701650003777465,0,0,6
27,Aflatoxin B1 metabolism WP699,0.019233647859433222,22.31357552581262,88.16303529551985,"['AKR7A2', 'AKR7A3']",0.27617356897483125,0,0,2
28,Translation Factors WP107,0.019671083933684424,2.6328054298642534,10.343254003212984,"['EEF1B2', 'EIF5', 'EIF1AY', 'EIF3I', 'EIF3J', 'EIF4H', 'EIF2S1', 'EIF1']",0.27617356897483125,0,0,8
29,Eukaryotic Transcription Initiation WP405,0.020327496193578952,3.1944063613929257,12.444707024855138,"['GTF2A2', 'POLR3H', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.27617356897483125,0,0,6
30,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.02279688861574594,6.698181818181818,25.326704366891754,"['IDI1', 'HMGCS1', 'PMVK']",0.29849567024211715,0,0,3
31,Unfolded protein response WP4925,0.023485699942907695,4.467816091954023,16.760402462798343,"['XBP1', 'DDIT3', 'TNFRSF10B', 'EIF2S1']",0.29849567024211715,0,0,4
32,Synaptic Vesicle Pathway WP2267,0.033429968820675234,2.524867528121223,8.580263661326201,"['RAB3A', 'CLTC', 'AP2S1', 'PARK7', 'SLC25A4', 'AP2M1', 'VAMP2']",0.4116064911045638,0,0,7
33,Mevalonate pathway WP3963,0.03637319736152514,11.155831739961759,36.96956863429912,"['HMGCS1', 'PMVK']",0.4342739321345729,0,0,2
34,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.04390430170918414,2.5789901077808945,8.061260211686092,"['IDI1', 'SQLE', 'NSDHL', 'HMGCS1', 'PMVK', 'FDFT1']",0.5087733786299574,0,0,6
35,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.05006868136034262,2.4832586905523564,7.435769471799379,"['XBP1', 'MAP1LC3A', 'PPP1R11', 'PPP1R7', 'DDIT3', 'EIF2S1']",0.5510807906437967,0,0,6
36,Melanoma WP4685,0.05551943129218544,2.0801431127012524,6.013739930752739,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'CALM3', 'HRAS', 'CALM2']",0.5510807906437967,0,0,8
37,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.05579369715962778,4.1852870813397125,12.079133482720215,"['LDHA', 'PDHA1', 'RPS6']",0.5510807906437967,0,0,3
38,RalA downstream regulated genes WP2290,0.05579369715962778,4.1852870813397125,12.079133482720215,"['RAC3', 'KRAS', 'HRAS']",0.5510807906437967,0,0,3
39,Androgen receptor signaling pathway WP138,0.05583336780067216,1.9736171658268697,5.694642601099823,"['CCND1', 'SUMO1', 'PRDX1', 'BAG1', 'RACK1', 'DSTN', 'STUB1', 'PARK7', 'RAN']",0.5510807906437967,0,0,9
40,Copper homeostasis WP3286,0.05673710062119337,2.3943652316972854,6.870216688138703,"['CCND1', 'COX17', 'COX11', 'MT3', 'ATOX1', 'SOD1']",0.5510807906437967,0,0,6
41,Peroxiredoxin 2 induced ovarian failure WP4873,0.057345970599989,7.436583811344805,21.25861037385013,"['STAR', 'BAX']",0.5510807906437967,0,0,2
42,Cytosolic DNA-sensing pathway WP4655,0.06391303323139899,2.3116023562115298,6.357442714609873,"['POLR3GL', 'POLR3H', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L']",0.599565121265981,0,0,6
43,DNA Repair Pathways Full Network WP4946,0.06769766646659593,1.7579694172751068,4.733690523023545,"['POLE4', 'POLD4', 'NEIL2', 'CENPX', 'APEX1', 'POLD2', 'POLE3', 'RPA2', 'RAD23A', 'GTF2H5', 'RBX1']",0.6126517652317214,0,0,11
44,Cori Cycle WP1946,0.06997291734880066,3.7199362041467303,9.893717190894531,"['LDHA', 'TPI1', 'PGK1']",0.6126517652317214,0,0,3
45,TP53 network WP1742,0.06997291734880066,3.7199362041467303,9.893717190894531,"['SUMO1', 'GADD45A', 'BAX']",0.6126517652317214,0,0,3
46,DNA damage response WP707,0.07338416733514098,2.0585216643915265,5.376955483055273,"['CCNB1', 'CCND1', 'GADD45A', 'RPA2', 'TNFRSF10B', 'CYCS', 'BAX']",0.6285513463053379,0,0,7
47,miRNA regulation of DNA damage response WP1530,0.08071001473585541,2.0055666395724034,5.04779586015551,"['CCNB1', 'CCND1', 'GADD45A', 'RPA2', 'TNFRSF10B', 'CYCS', 'BAX']",0.6492818195894628,0,0,7
48,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.08140512477661023,5.576959847036329,13.9887834715524,"['COX8A', 'COX5A']",0.6492818195894628,0,0,2
49,TCA cycle in senescence WP5050,0.08140512477661023,5.576959847036329,13.9887834715524,"['PDHA1', 'GOT1']",0.6492818195894628,0,0,2
50,Mitochondrial CII Assembly WP4920,0.0823961699986628,inf,inf,['SDHAF1'],0.6492818195894628,0,0,1
51,Nanomaterial induced apoptosis WP2507,0.10252589420563847,3.0430622009569377,6.930999844210302,"['ENDOG', 'BAX', 'CYCS']",0.7920627905298344,0,0,3
52,Trans-sulfuration pathway WP2333,0.10790067397642306,4.461185468451243,9.933026453381997,"['AHCY', 'GOT1']",0.8175551066675131,0,0,2
53,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.1140395942329617,1.8183767843978285,3.9480770817064803,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'CYCS', 'BAX', 'KRAS']",0.832066669033091,0,0,7
54,Leptin signaling pathway WP2034,0.1140395942329617,1.8183767843978285,3.9480770817064803,"['CCND1', 'BAD', 'CFL2', 'RPS6', 'BAX', 'IKBKG', 'HRAS']",0.832066669033091,0,0,7
55,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.12066067212902458,2.7892344497607655,5.898597804173508,"['RRAS', 'KRAS', 'HRAS']",0.8643691785242852,0,0,3
56,Non-small cell lung cancer WP4255,0.123349623495293,1.776897214217099,3.7185705286326445,"['CCND1', 'BAD', 'GADD45A', 'CYCS', 'BAX', 'KRAS', 'HRAS']",0.8678527081633115,0,0,7
57,Myometrial relaxation and contraction pathways WP289,0.12627316752116133,1.507353260162249,3.1191777418549584,"['RGS4', 'CNN1', 'GNG3', 'YWHAQ', 'PRKAR1A', 'GSTO1', 'CRH', 'CALM3', 'IGFBP6', 'CALM2', 'ACTG1', 'YWHAH']",0.8728355790059222,0,0,12
58,CAMKK2  Pathway WP4874,0.13053864128487475,2.2319923371647508,4.5445283369723946,"['FIS1', 'MAP1LC3A', 'SQSTM1', 'CALM2']",0.8867624942455284,0,0,4
59,Glycolysis in senescence WP5049,0.1362686219602194,3.717335882727852,7.409123184461488,"['LDHA', 'PGK1']",0.8888144388920135,0,0,2
60,HIF1A and PPARG regulation of glycolysis WP2456,0.1362686219602194,3.717335882727852,7.409123184461488,"['LDHA', 'TPI1']",0.8888144388920135,0,0,2
61,Methionine De Novo and Salvage Pathway WP3580,0.13986420104392092,2.5744571218255428,5.0641716615318275,"['AHCY', 'ODC1', 'TXN']",0.8888144388920135,0,0,3
62,Photodynamic therapy-induced unfolded protein response WP3613,0.13986420104392092,2.5744571218255428,5.0641716615318275,"['NARS', 'XBP1', 'DDIT3']",0.8888144388920135,0,0,3
63,miRNA regulation of prostate cancer signaling pathways WP3981,0.14586863293790536,2.125524539317643,4.091738541815546,"['CCND1', 'BAD', 'KRAS', 'IKBKG']",0.8980037715239799,0,0,4
64,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.14586863293790536,2.125524539317643,4.091738541815546,"['LDHA', 'PDHA1', 'PGK1', 'BAX']",0.8980037715239799,0,0,4
65,Pathogenic Escherichia coli infection WP2272,0.1506088987258422,1.7627538135165168,3.3370143819643463,"['TUBA1A', 'YWHAQ', 'ARPC2', 'ARPC3', 'ARPC5L', 'ACTG1']",0.9085050396754152,0,0,6
66,GABA metabolism (aka GHB) WP4157,0.15800926740161292,11.146131805157593,20.565745552100086,['AKR7A2'],0.9085050396754152,0,0,1
67,miRNA Biogenesis WP2338,0.15800926740161292,11.146131805157593,20.565745552100086,['RAN'],0.9085050396754152,0,0,1
68,GABA receptor Signaling WP4159,0.16000565451359225,2.390362269309638,4.380449110773254,"['GABRB3', 'AP2S1', 'AP2M1']",0.9085050396754152,0,0,3
69,Statin inhibition of cholesterol production WP430,0.16000565451359225,2.390362269309638,4.380449110773254,"['SQLE', 'APOC1', 'FDFT1']",0.9085050396754152,0,0,3
70,Galanin receptor pathway WP4970,0.16602122552444135,3.186014750068287,5.720934360350924,"['POMC', 'VAMP2']",0.9085050396754152,0,0,2
71,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.16602122552444135,3.186014750068287,5.720934360350924,"['IDH3B', 'DLD']",0.9085050396754152,0,0,2
72,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.16602122552444135,3.186014750068287,5.720934360350924,"['PDHA1', 'DLD']",0.9085050396754152,0,0,2
73,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.17475657398006245,1.6743282149712093,2.920633306923976,"['PSMD8', 'PSMC5', 'TUBA1A', 'PSMD7', 'PSMD4', 'STUB1']",0.9374202066933525,0,0,6
74,Amyotrophic lateral sclerosis (ALS) WP2447,0.17844293274619655,1.9403631517574547,3.3441895678881637,"['BAD', 'NEFL', 'BAX', 'SOD1']",0.9374202066933525,0,0,4
75,Metabolic reprogramming in colon cancer WP4290,0.17844293274619655,1.9403631517574547,3.3441895678881637,"['LDHA', 'PDHA1', 'PGK1', 'PYCR2']",0.9374202066933525,0,0,4
76,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.18547587637409788,1.7436181687440078,2.9377009871724984,"['BEX3', 'SERBP1', 'TNFRSF10B', 'RNF7', 'SQSTM1']",0.9453034257245425,0,0,5
77,Modulators of TCR signaling and T cell activation WP5072,0.18547587637409788,1.7436181687440078,2.9377009871724984,"['NDUFB10', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D']",0.9453034257245425,0,0,5
78,Senescence and Autophagy in Cancer WP615,0.19505220358162945,1.4885897435897435,2.4330821406577443,"['GABARAPL2', 'GABARAPL1', 'MAP1LC3B', 'RNASEL', 'MAP1LC3A', 'SQSTM1', 'HRAS', 'GABARAP']",0.9453034257245425,0,0,8
79,Bladder cancer WP2828,0.19556793008818654,1.8593550446998723,3.0341838653677375,"['CCND1', 'DAPK1', 'KRAS', 'HRAS']",0.9453034257245425,0,0,4
80,Cysteine and methionine catabolism WP4504,0.19673827641982866,2.7875239005736137,4.532182090223869,"['AHCY', 'GOT1']",0.9453034257245425,0,0,2
81,Homologous recombination WP186,0.19673827641982866,2.7875239005736137,4.532182090223869,"['POLD4', 'POLD2']",0.9453034257245425,0,0,2
82,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.19673827641982866,2.7875239005736137,4.532182090223869,"['RRAS', 'IKBKG']",0.9453034257245425,0,0,2
83,Endometrial cancer WP4155,0.20036059764107525,1.5943241020016452,2.5630936951944876,"['CCND1', 'BAD', 'GADD45A', 'BAX', 'KRAS', 'HRAS']",0.9502116759827621,0,0,6
84,Canonical and non-canonical Notch signaling WP3845,0.20258319995571578,2.091208133971292,3.338832553103313,"['RRAS', 'NOTCH4', 'DLL3']",0.9502116759827621,0,0,3
85,Alzheimer's disease WP2059,0.21025374022264634,1.5024939037907337,2.343049380125176,"['PSENEN', 'ATP5MD', 'BAD', 'CHP1', 'CYCS', 'CALM3', 'CALM2']",0.9588223353603126,0,0,7
86,NO/cGMP/PKG mediated Neuroprotection WP4008,0.21317012401336863,1.7848275862068965,2.7587450451671627,"['BAD', 'NEFL', 'CYCS', 'CALM2']",0.9588223353603126,0,0,4
87,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.22476724146900856,1.9680270194202083,2.9376540441565395,"['BAD', 'KRAS', 'HRAS']",0.9588223353603126,0,0,3
88,Gastric acid production WP2596,0.22739710556061676,5.5725883476599805,8.253323355190405,['CCK'],0.9588223353603126,0,0,1
89,MED and Pseudoachondroplasia genes WP4789,0.22739710556061676,5.5725883476599805,8.253323355190405,['COL9A3'],0.9588223353603126,0,0,1
90,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.22739710556061676,5.5725883476599805,8.253323355190405,['MAS1'],0.9588223353603126,0,0,1
91,The alternative pathway of fetal androgen synthesis WP4524,0.22739710556061676,5.5725883476599805,8.253323355190405,['STAR'],0.9588223353603126,0,0,1
92,PPAR-alpha pathway WP2878,0.22805929993112706,2.4775865731888675,3.662243593272924,"['CCND1', 'DBI']",0.9588223353603126,0,0,2
93,Notch Signaling Pathway Netpath WP61,0.23066222811379497,1.5937542802355842,2.3377201401109104,"['PSENEN', 'CCND1', 'NOTCH4', 'SKP1', 'DLL3']",0.9588223353603126,0,0,5
94,DNA Replication WP466,0.23118812654626827,1.7160330091364575,2.5131706674057606,"['POLD4', 'POLD2', 'RPA2', 'UBA52']",0.9588223353603126,0,0,4
95,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.23118812654626827,1.7160330091364575,2.5131706674057606,"['YWHAQ', 'LIMD1', 'ACTG1', 'PAK4']",0.9588223353603126,0,0,4
96,Pancreatic adenocarcinoma pathway WP4263,0.23986659180013029,1.3950721153846153,1.9917059240218702,"['CCND1', 'BAD', 'GADD45A', 'RAC3', 'BAX', 'KRAS', 'IKBKG', 'PAK4']",0.9844524705130347,0,0,8
97,Integrated breast cancer pathway WP1984,0.24504438647968502,1.328906321680888,1.8688621104438774,"['CCND1', 'RRAS', 'GADD45A', 'BAD', 'ODC1', 'BAX', 'KRAS', 'PHB', 'FAU', 'CCNB1IP1']",0.985210088441487,0,0,10
98,MET in type 1 papillary renal cell carcinoma WP4205,0.24638159379420044,1.5493501651219772,2.1704439768436323,"['BAD', 'RPL11', 'KRAS', 'HRAS', 'PAK4']",0.985210088441487,0,0,5
99,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.24755278872006908,1.4201729106628243,1.9827480393918446,"['CCND1', 'RRAS', 'BAD', 'RPS6', 'BAX', 'KRAS', 'HRAS']",0.985210088441487,0,0,7
100,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2596765788631294,2.2296367112810707,3.006260091065429,"['BAD', 'BAX']",0.9992483013234335,0,0,2
101,G Protein Signaling Pathways WP35,0.2604179800690088,1.3946926032660902,1.8765133235298492,"['GNG3', 'PDE1C', 'RRAS', 'PRKAR1A', 'KRAS', 'HRAS', 'CALM2']",0.9992483013234335,0,0,7
102,Endothelin Pathways WP2197,0.2703319602559314,1.7605640896499621,2.3030019715000303,"['CNN1', 'RIIAD1', 'CALM2']",0.9992483013234335,0,0,3
103,Cell cycle WP179,0.27635822713615155,1.3042760896466383,1.6773738260003748,"['CDKN2D', 'CCNB1', 'CCND1', 'YWHAQ', 'GADD45A', 'SKP1', 'RBX1', 'ANAPC11', 'YWHAH']",0.9992483013234335,0,0,9
104,Cell Differentiation - Index WP2029,0.29107174765932375,3.71474052849411,4.584678847012804,['MEF2D'],0.9992483013234335,0,0,1
105,Glucuronidation WP698,0.29107174765932375,3.71474052849411,4.584678847012804,['UGP2'],0.9992483013234335,0,0,1
106,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.2913289199355312,2.026768642447419,2.4996185115420566,"['CD63', 'SOD1']",0.9992483013234335,0,0,2
107,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.2913289199355312,2.026768642447419,2.4996185115420566,"['LDHA', 'PDHA1']",0.9992483013234335,0,0,2
108,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.2913289199355312,2.026768642447419,2.4996185115420566,"['KRAS', 'HRAS']",0.9992483013234335,0,0,2
109,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.29498893876878907,1.429800624431497,1.7455255080664152,"['IDI1', 'SQLE', 'HMGCS1', 'DBI', 'FDFT1']",0.9992483013234335,0,0,5
110,TNF-alpha signaling pathway WP231,0.3000445586188468,1.323434116478614,1.5931821311660423,"['BAD', 'BAX', 'KRAS', 'IKBKG', 'TXN', 'HRAS', 'SKP1']",0.9992483013234335,0,0,7
111,PPAR signaling pathway WP3942,0.3062151079137179,1.4867177522349937,1.759482077450462,"['FABP3', 'FABP5', 'FABP6', 'DBI']",0.9992483013234335,0,0,4
112,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.3115513504732604,1.393935762224353,1.625595487278725,"['BAD', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9992483013234335,0,0,5
113,22q11.2 copy number variation syndrome WP4657,0.31353296202902164,1.3012648094780659,1.5092730073799263,"['RANBP1', 'MRPL40', 'DGCR6L', 'EMC10', 'RAN', 'RBX1', 'PAK4']",0.9992483013234335,0,0,7
114,MAPK Cascade WP422,0.31677254647149067,1.5926179084073822,1.8308278101660573,"['RRAS', 'KRAS', 'HRAS']",0.9992483013234335,0,0,3
115,Parkinson's disease pathway WP2371,0.31677254647149067,1.5926179084073822,1.8308278101660573,"['PINK1', 'CYCS', 'PARK7']",0.9992483013234335,0,0,3
116,Type 2 papillary renal cell carcinoma WP4241,0.31677254647149067,1.5926179084073822,1.8308278101660573,"['ELOB', 'ELOC', 'RBX1']",0.9992483013234335,0,0,3
117,IL-18 signaling pathway WP4754,0.3215919043189175,1.1706009382679277,1.3280138882919785,"['NRN1', 'IMP3', 'BAD', 'COX17', 'NDUFC1', 'BPGM', 'RND2', 'PTMS', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'RPS11', 'AARS', 'ITM2C']",0.9992483013234335,0,0,15
118,miRNA regulation of p53 pathway in prostate cancer WP3982,0.32279608768366386,1.8577119184193753,2.100578887737455,"['TNFRSF10B', 'BAX']",0.9992483013234335,0,0,2
119,Nucleotide metabolism WP404,0.32279608768366386,1.8577119184193753,2.100578887737455,"['NME2', 'OAZ1']",0.9992483013234335,0,0,2
120,Serotonin and anxiety WP3947,0.32279608768366386,1.8577119184193753,2.100578887737455,"['POMC', 'CRH']",0.9992483013234335,0,0,2
121,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.3254221089438517,1.4386355209492028,1.615058477316611,"['RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.9992483013234335,0,0,4
122,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3343491683204936,1.2242188783774266,1.3412167640114863,"['GABRB3', 'RAB3A', 'BAD', 'RPS6', 'RACK1', 'IKBKG', 'SQSTM1', 'EIF2S1', 'HRAS']",0.9992483013234335,0,0,9
123,ATM Signaling Pathway WP2516,0.3400776217511241,1.5200956937799044,1.6395469235335174,"['CCNB1', 'GADD45A', 'IKBKG']",0.9992483013234335,0,0,3
124,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.3400776217511241,1.5200956937799044,1.6395469235335174,"['MAP1LC3A', 'ATG101', 'FTL']",0.9992483013234335,0,0,3
125,p38 MAPK Signaling Pathway WP400,0.3400776217511241,1.5200956937799044,1.6395469235335174,"['DDIT3', 'HRAS', 'MEF2D']",0.9992483013234335,0,0,3
126,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3400776217511241,1.5200956937799044,1.6395469235335174,"['STAR', 'CALM3', 'CALM2']",0.9992483013234335,0,0,3
127,Acute viral myocarditis WP4298,0.345000987621869,1.3273295895539423,1.4125547668880487,"['ENDOG', 'CCND1', 'RAC3', 'CYCS', 'BAX']",0.9992483013234335,0,0,5
128,Acetylcholine Synthesis WP528,0.34950318550392867,2.785816618911175,2.928569113636604,['PDHA1'],0.9992483013234335,0,0,1
129,Alanine and aspartate metabolism WP106,0.34950318550392867,2.785816618911175,2.928569113636604,['GOT1'],0.9992483013234335,0,0,1
130,"Degradation pathway of sphingolipids, including diseases WP4153",0.34950318550392867,2.785816618911175,2.928569113636604,['GM2A'],0.9992483013234335,0,0,1
131,Glial Cell Differentiation WP2276,0.34950318550392867,2.785816618911175,2.928569113636604,['GAP43'],0.9992483013234335,0,0,1
132,let-7 inhibition of ES cell reprogramming WP3299,0.34950318550392867,2.785816618911175,2.928569113636604,['TRIM71'],0.9992483013234335,0,0,1
133,Molybdenum cofactor (Moco) biosynthesis WP4507,0.34950318550392867,2.785816618911175,2.928569113636604,['MOCS2'],0.9992483013234335,0,0,1
134,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.34950318550392867,2.785816618911175,2.928569113636604,['MEF2D'],0.9992483013234335,0,0,1
135,IL-7 signaling pathway WP205,0.3538938383876067,1.714663921164877,1.7811213839104845,"['CCND1', 'BAD']",0.9992483013234335,0,0,2
136,"Relationship between inflammation, COX-2 and EGFR WP4483",0.3538938383876067,1.714663921164877,1.7811213839104845,"['KRAS', 'HRAS']",0.9992483013234335,0,0,2
137,Small cell lung cancer WP4658,0.3545687509970699,1.2389796136193831,1.2846397465183599,"['CCND1', 'GADD45A', 'CYCS', 'BAX', 'IKBKG', 'CKS1B', 'SKP1']",0.9992483013234335,0,0,7
138,Fas ligand pathway and stress induction of heat shock proteins WP314,0.36332386832325225,1.4538797586852508,1.471996035690751,"['ARHGDIB', 'CYCS', 'ACTG1']",0.9992483013234335,0,0,3
139,G1 to S cell cycle control WP45,0.3786569840063162,1.266778523489933,1.2301997097683892,"['CDKN2D', 'CCNB1', 'CCND1', 'GADD45A', 'RPA2']",0.9992483013234335,0,0,5
140,Genotoxicity pathway WP4286,0.38327454855409554,1.3113590263691683,1.257598170971728,"['RPS27', 'GADD45A', 'BLOC1S2', 'TRIAP1']",0.9992483013234335,0,0,4
141,Prader-Willi and Angelman Syndrome WP3998,0.38327454855409554,1.3113590263691683,1.257598170971728,"['GABRB3', 'POMC', 'CCND1', 'FEZ1']",0.9992483013234335,0,0,4
142,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3844694933077038,1.592051352089593,1.521827295334995,"['H3F3B', 'H2AFZ']",0.9992483013234335,0,0,2
143,Striated Muscle Contraction Pathway WP383,0.3844694933077038,1.592051352089593,1.521827295334995,"['TPM3', 'ACTG1']",0.9992483013234335,0,0,2
144,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.3864339793145197,1.393181818181818,1.3246292512398927,"['NDUFA13', 'COPS6', 'IKBKG']",0.9992483013234335,0,0,3
145,Ras signaling WP4223,0.4020784171939835,1.125175833606115,1.0251568628871846,"['GNG3', 'RASA4B', 'RRAS', 'BAD', 'RAC3', 'CALM3', 'KRAS', 'IKBKG', 'CALM2', 'HRAS', 'PAK4']",0.9992483013234335,0,0,11
146,Canonical NF-KB pathway WP4562,0.40312278375480126,2.2284622731614134,2.0245893722166195,['IKBKG'],0.9992483013234335,0,0,1
147,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.40312278375480126,2.2284622731614134,2.0245893722166195,['IKBKG'],0.9992483013234335,0,0,1
148,G13 Signaling Pathway WP524,0.4093378982596909,1.3373397129186604,1.1945309647713347,"['CFL2', 'ARHGDIB', 'CALM2']",0.9992483013234335,0,0,3
149,Glycogen Synthesis and Degradation WP500,0.4093378982596909,1.3373397129186604,1.1945309647713347,"['UGP2', 'CALM3', 'CALM2']",0.9992483013234335,0,0,3
150,Histone Modifications WP2369,0.4093378982596909,1.3373397129186604,1.1945309647713347,"['SET', 'H3F3B', 'SETD9']",0.9992483013234335,0,0,3
151,Sleep regulation WP3591,0.4093378982596909,1.3373397129186604,1.1945309647713347,"['AHCY', 'STAR', 'CRH']",0.9992483013234335,0,0,3
152,Intraflagellar transport proteins binding to dynein WP4532,0.41439799586123494,1.48578712555768,1.308872111349013,"['IFT22', 'DYNLL1']",0.9992483013234335,0,0,2
153,SARS-CoV-2 mitochondrial interactions WP5038,0.41439799586123494,1.48578712555768,1.308872111349013,"['NDUFB9', 'PHB']",0.9992483013234335,0,0,2
154,Apoptosis Modulation and Signaling WP1772,0.41891960167848596,1.1732498232144661,1.0208168169459666,"['ENDOG', 'AIFM2', 'BAD', 'TNFRSF10B', 'CYCS', 'BAX']",0.9992483013234335,0,0,6
155,Exercise-induced Circadian Regulation WP410,0.4215683321712206,1.2382928905917412,1.069604457852928,"['IDI1', 'UGP2', 'SUMO1', 'STBD1']",0.9992483013234335,0,0,4
156,Amino Acid metabolism WP3925,0.4289750371215296,1.1856143285530691,1.0034524530708346,"['LDHA', 'PDHA1', 'GOT1', 'ODC1', 'DLD']",0.9992483013234335,0,0,5
157,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4319726336057335,1.285793154214207,1.0792858256578823,"['STAR', 'KRAS', 'HRAS']",0.9992483013234335,0,0,3
158,Oxidative Damage WP3941,0.4319726336057335,1.285793154214207,1.0792858256578823,"['BAD', 'GADD45A', 'CYCS']",0.9992483013234335,0,0,3
159,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4405074323123828,1.204721963342653,0.9876647511434595,"['TMSB4X', 'NEFL', 'PFN2', 'SOD1']",0.9992483013234335,0,0,4
160,Proximal tubule transport WP4917,0.4405074323123828,1.204721963342653,0.9876647511434595,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9992483013234335,0,0,4
161,Fatty acid beta-oxidation WP143,0.4435784032002063,1.3928059273422562,1.1321850711000165,"['TPI1', 'DLD']",0.9992483013234335,0,0,2
162,ACE Inhibitor Pathway WP554,0.45232645004643346,1.8568927093282395,1.4731679203580257,['MAS1'],0.9992483013234335,0,0,1
163,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.45232645004643346,1.8568927093282395,1.4731679203580257,['NSDHL'],0.9992483013234335,0,0,1
164,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.45232645004643346,1.8568927093282395,1.4731679203580257,['STAR'],0.9992483013234335,0,0,1
165,Insulin signaling in adipocytes (diabetic condition) WP3635,0.45232645004643346,1.8568927093282395,1.4731679203580257,['RPS6'],0.9992483013234335,0,0,1
166,Insulin signaling in adipocytes (normal condition) WP3634,0.45232645004643346,1.8568927093282395,1.4731679203580257,['RPS6'],0.9992483013234335,0,0,1
167,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.45232645004643346,1.8568927093282395,1.4731679203580257,['SQSTM1'],0.9992483013234335,0,0,1
168,Iron metabolism in placenta WP2007,0.45232645004643346,1.8568927093282395,1.4731679203580257,['FTH1'],0.9992483013234335,0,0,1
169,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.45232645004643346,1.8568927093282395,1.4731679203580257,['BAX'],0.9992483013234335,0,0,1
170,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.45232645004643346,1.8568927093282395,1.4731679203580257,['AHCY'],0.9992483013234335,0,0,1
171,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.45232645004643346,1.8568927093282395,1.4731679203580257,['VEGFB'],0.9992483013234335,0,0,1
172,NLR Proteins WP288,0.45232645004643346,1.8568927093282395,1.4731679203580257,['IKBKG'],0.9992483013234335,0,0,1
173,Purine metabolism WP4792,0.45232645004643346,1.8568927093282395,1.4731679203580257,['APRT'],0.9992483013234335,0,0,1
174,Role of Osx and miRNAs in tooth development WP3971,0.45232645004643346,1.8568927093282395,1.4731679203580257,['NOTCH4'],0.9992483013234335,0,0,1
175,Supression of HMGB1 mediated inflammation by THBD WP4479,0.45232645004643346,1.8568927093282395,1.4731679203580257,['IKBKG'],0.9992483013234335,0,0,1
176,Thiamine metabolic pathways WP4297,0.45232645004643346,1.8568927093282395,1.4731679203580257,['PDHA1'],0.9992483013234335,0,0,1
177,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.4542820146120216,1.2380648591174908,0.976879101385182,"['BANF1', 'KRAS', 'HRAS']",0.9992483013234335,0,0,3
178,Regulation of Actin Cytoskeleton WP51,0.45432568273411983,1.0902100682093987,0.8601113944645277,"['RRAS', 'CFL2', 'TMSB4X', 'BRK1', 'RAC3', 'KRAS', 'ACTG1', 'SSH1', 'PAK4']",0.9992483013234335,0,0,9
179,16p11.2 proximal deletion syndrome WP4949,0.4620776268584835,1.1370262390670554,0.8778097015145959,"['TMEM219', 'SEZ6L2', 'CCT7', 'CDIPT', 'CCT4']",0.9992483013234335,0,0,5
180,Apoptosis WP254,0.4620776268584835,1.1370262390670554,0.8778097015145959,"['BAD', 'TNFRSF10B', 'CYCS', 'BAX', 'IKBKG']",0.9992483013234335,0,0,5
181,Autophagy WP4923,0.4719307678382922,1.3107636936227647,0.9842825821202106,"['MAP1LC3B', 'ATG101']",0.9992483013234335,0,0,2
182,Gastric Cancer Network 2 WP2363,0.4719307678382922,1.3107636936227647,0.9842825821202106,"['S100A6', 'COL9A3']",0.9992483013234335,0,0,2
183,Aryl Hydrocarbon Receptor Netpath WP2586,0.4762164033483753,1.1937457279562542,0.8856195415398957,"['AIP', 'KRAS', 'HRAS']",0.9992483013234335,0,0,3
184,DNA damage response (only ATM dependent) WP710,0.47861798134758116,1.0959378244863283,0.8075445625219787,"['CCND1', 'BAD', 'RAC3', 'BAX', 'KRAS', 'HRAS']",0.9992483013234335,0,0,6
185,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4960700648164678,1.114080459770115,0.7810128515749728,"['APEX1', 'RPS6', 'HRAS', 'MYL12B']",0.9992483013234335,0,0,4
186,Dopamine metabolism WP2436,0.49747754650320297,1.5914858780188292,1.1111831683818723,['SOD1'],0.9992483013234335,0,0,1
187,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.49747754650320297,1.5914858780188292,1.1111831683818723,['MAP1LC3A'],0.9992483013234335,0,0,1
188,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.49747754650320297,1.5914858780188292,1.1111831683818723,['CCND1'],0.9992483013234335,0,0,1
189,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.49747754650320297,1.5914858780188292,1.1111831683818723,['DLL3'],0.9992483013234335,0,0,1
190,IL-3 signaling pathway WP286,0.49773237430311457,1.152483088599241,0.8040790924248137,"['YWHAQ', 'BAD', 'HRAS']",0.9992483013234335,0,0,3
191,Nanoparticle-mediated activation of receptor signaling WP2643,0.49939336848587645,1.2378372636498831,0.8595061432681632,"['KRAS', 'HRAS']",0.9992483013234335,0,0,2
192,Hippo-Merlin Signaling Dysregulation WP4541,0.5187748874182632,1.0396669868715978,0.6823180905571451,"['CCND1', 'PRKAR1A', 'KRAS', 'ITGAE', 'HRAS', 'RBX1', 'PAK4']",0.9992483013234335,0,0,7
193,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5259202539828723,1.1725872999899365,0.7535112664640681,"['RAB3A', 'NEFL']",0.9992483013234335,0,0,2
194,Lipid Metabolism Pathway WP3965,0.5259202539828723,1.1725872999899365,0.7535112664640681,"['PDHA1', 'PRKAR1A']",0.9992483013234335,0,0,2
195,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5259202539828723,1.1725872999899365,0.7535112664640681,"['CCND1', 'TPM3']",0.9992483013234335,0,0,2
196,Cell Differentiation - Index expanded WP2023,0.5389095625843969,1.3924307545367718,0.8608111490025205,['MEF2D'],0.9992483013234335,0,0,1
197,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5389095625843969,1.3924307545367718,0.8608111490025205,['CCK'],0.9992483013234335,0,0,1
198,Glutathione metabolism WP100,0.5389095625843969,1.3924307545367718,0.8608111490025205,['GPX4'],0.9992483013234335,0,0,1
199,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.5389095625843969,1.3924307545367718,0.8608111490025205,['CCND1'],0.9992483013234335,0,0,1
200,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.5389095625843969,1.3924307545367718,0.8608111490025205,['HMGCS1'],0.9992483013234335,0,0,1
201,Sulfation Biotransformation Reaction WP692,0.5389095625843969,1.3924307545367718,0.8608111490025205,['SULT4A1'],0.9992483013234335,0,0,1
202,Kit receptor signaling pathway WP304,0.5393643536447777,1.0779441271801204,0.6654838503333207,"['BAD', 'RPS6', 'HRAS']",0.9992483013234335,0,0,3
203,ErbB signaling pathway WP673,0.5418910773524255,1.0313021554632293,0.6318687878659002,"['CCND1', 'BAD', 'KRAS', 'HRAS', 'PAK4']",0.9992483013234335,0,0,5
204,Glycosylation and related congenital defects WP4521,0.5514790679527735,1.1138623326959847,0.6629167219925113,"['DPM2', 'DPM3']",0.9992483013234335,0,0,2
205,IL-2 signaling pathway WP49,0.5514790679527735,1.1138623326959847,0.6629167219925113,"['RPS6', 'HRAS']",0.9992483013234335,0,0,2
206,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5594214270156298,1.0441686602870814,0.6065076586751558,"['TKFC', 'PIN1', 'IKBKG']",0.9992483013234335,0,0,3
207,Aryl Hydrocarbon Receptor Pathway WP2873,0.5760491237480646,1.0607302194300283,0.5850588394319989,"['AIP', 'BAX']",0.9992483013234335,0,0,2
208,BDNF-TrkB Signaling WP3676,0.5760491237480646,1.0607302194300283,0.5850588394319989,"['KRAS', 'HRAS']",0.9992483013234335,0,0,2
209,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.5760491237480646,1.0607302194300283,0.5850588394319989,"['KRAS', 'HRAS']",0.9992483013234335,0,0,2
210,IL-5 signaling pathway WP127,0.5760491237480646,1.0607302194300283,0.5850588394319989,"['RPS6', 'KRAS']",0.9992483013234335,0,0,2
211,Biomarkers for urea cycle disorders WP4583,0.5769285687284189,1.2376101029396158,0.680731122741748,['GOT1'],0.9992483013234335,0,0,1
212,Nanoparticle triggered autophagic cell death WP2509,0.5769285687284189,1.2376101029396158,0.680731122741748,['MAP1LC3A'],0.9992483013234335,0,0,1
213,Nanoparticle triggered regulated necrosis WP2513,0.5769285687284189,1.2376101029396158,0.680731122741748,['FTL'],0.9992483013234335,0,0,1
214,Osteoclast Signaling WP12,0.5769285687284189,1.2376101029396158,0.680731122741748,['ATP6V1G1'],0.9992483013234335,0,0,1
215,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.5769285687284189,1.2376101029396158,0.680731122741748,['RNASEL'],0.9992483013234335,0,0,1
216,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5769285687284189,1.2376101029396158,0.680731122741748,['ANAPC11'],0.9992483013234335,0,0,1
217,Serotonin and anxiety-related events WP3944,0.5769285687284189,1.2376101029396158,0.680731122741748,['CRH'],0.9992483013234335,0,0,1
218,Folate Metabolism WP176,0.5789414841463012,1.0124401913875598,0.5533531049155083,"['AHCY', 'GPX4', 'SOD1']",0.9992483013234335,0,0,3
219,Breast cancer pathway WP4262,0.5878481947615015,0.96814381270903,0.5143617731752184,"['CCND1', 'GADD45A', 'NOTCH4', 'BAX', 'KRAS', 'HRAS', 'SKP1', 'DLL3']",0.9992483013234335,0,0,8
220,TGF-beta Signaling Pathway WP366,0.6074648784409424,0.9503409011035355,0.47370779864664775,"['PARD6A', 'CCND1', 'CITED1', 'SUMO1', 'STRAP', 'SKP1', 'RBX1']",0.9992483013234335,0,0,7
221,ERK Pathway in Huntington's Disease WP3853,0.6118154687065273,1.113753581661891,0.5472144925325473,['HRAS'],0.9992483013234335,0,0,1
222,Genes targeted by miRNAs in adipocytes WP1992,0.6118154687065273,1.113753581661891,0.5472144925325473,['TMSB4X'],0.9992483013234335,0,0,1
223,Hedgehog Signaling Pathway Netpath WP47,0.6118154687065273,1.113753581661891,0.5472144925325473,['SAP18'],0.9992483013234335,0,0,1
224,Purine metabolism and related disorders WP4224,0.6118154687065273,1.113753581661891,0.5472144925325473,['APRT'],0.9992483013234335,0,0,1
225,Transcriptional cascade regulating adipogenesis WP4211,0.6118154687065273,1.113753581661891,0.5472144925325473,['DDIT3'],0.9992483013234335,0,0,1
226,Retinoblastoma gene in cancer WP2446,0.615038502532295,0.9475829461155947,0.46059202865584187,"['CCNB1', 'CCND1', 'H2AFZ', 'RPA2']",0.9992483013234335,0,0,4
227,p53 transcriptional gene network WP4963,0.6163038805277408,0.9544224196855776,0.46195488632999687,"['SIVA1', 'GADD45A', 'BAX']",0.9992483013234335,0,0,3
228,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6341227125151817,0.9278309409888357,0.422638860959291,"['IFI27L2', 'KRAS', 'HRAS']",0.9992483013234335,0,0,3
229,Gastrin signaling pathway WP4659,0.6424408042066341,0.9148371151368548,0.4047976755969068,"['CCND1', 'BAD', 'RPS6', 'KRAS', 'HRAS', 'MEF2D']",0.9992483013234335,0,0,6
230,Airway smooth muscle cell contraction WP4962,0.6438280673018705,1.0124164278892072,0.44579081055139674,['CALM2'],0.9992483013234335,0,0,1
231,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.6438280673018705,1.0124164278892072,0.44579081055139674,['CCND1'],0.9992483013234335,0,0,1
232,miRNAs involved in DNA damage response WP1545,0.6438280673018705,1.0124164278892072,0.44579081055139674,['CCND1'],0.9992483013234335,0,0,1
233,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.6438280673018705,1.0124164278892072,0.44579081055139674,['GOT1'],0.9992483013234335,0,0,1
234,NOTCH1 regulation of endothelial cell calcification WP3413,0.6438280673018705,1.0124164278892072,0.44579081055139674,['DLL3'],0.9992483013234335,0,0,1
235,Overview of nanoparticle effects WP3287,0.6438280673018705,1.0124164278892072,0.44579081055139674,['BAX'],0.9992483013234335,0,0,1
236,Head and Neck Squamous Cell Carcinoma WP4674,0.660327343481743,0.8904980842911877,0.36957415156967494,"['CCND1', 'RPS6', 'KRAS', 'HRAS']",0.9992483013234335,0,0,4
237,PDGF Pathway WP2526,0.6643467143415862,0.8907074569789675,0.3642557993252247,"['ARFIP2', 'HRAS']",0.9992483013234335,0,0,2
238,Regulation of Microtubule Cytoskeleton WP2038,0.6643467143415862,0.8907074569789675,0.3642557993252247,"['PARD6A', 'CFL2']",0.9992483013234335,0,0,2
239,Hepatitis B infection WP4666,0.6651481151710896,0.8953371537094085,0.3650697254430214,"['YWHAQ', 'BAD', 'CYCS', 'BAX', 'KRAS', 'IKBKG', 'HRAS']",0.9992483013234335,0,0,7
240,Pathways in clear cell renal cell carcinoma WP4018,0.6694024458756607,0.8832884384178727,0.3545253360030757,"['LDHA', 'TPI1', 'PGK1', 'SQSTM1', 'PFKM']",0.9992483013234335,0,0,5
241,Apoptosis Modulation by HSP70 WP384,0.6732029677285565,0.927968799745304,0.3672050566849815,['CYCS'],0.9992483013234335,0,0,1
242,Hippo-Yap signaling pathway WP4537,0.6732029677285565,0.927968799745304,0.3672050566849815,['YWHAQ'],0.9992483013234335,0,0,1
243,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.6732029677285565,0.927968799745304,0.3672050566849815,['CCND1'],0.9992483013234335,0,0,1
244,MAPK pathway in congenital thyroid cancer WP4928,0.6732029677285565,0.927968799745304,0.3672050566849815,['KRAS'],0.9992483013234335,0,0,1
245,Common Pathways Underlying Drug Addiction WP2636,0.6839627577107529,0.8563759376378879,0.3252959504944718,"['CALM2', 'ACTG1']",0.9992483013234335,0,0,2
246,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.6839627577107529,0.8563759376378879,0.3252959504944718,"['CCND1', 'BAX']",0.9992483013234335,0,0,2
247,Rett syndrome causing genes WP4312,0.6839627577107529,0.8563759376378879,0.3252959504944718,"['IMPDH2', 'GPS2']",0.9992483013234335,0,0,2
248,Cannabinoid receptor signaling WP3869,0.7001573139332167,0.8565131143927706,0.3053043009036308,['PRKAR1A'],0.9992483013234335,0,0,1
249,Glycerolipids and Glycerophospholipids WP4722,0.7001573139332167,0.8565131143927706,0.3053043009036308,['CDIPT'],0.9992483013234335,0,0,1
250,Glycerophospholipid Biosynthetic Pathway WP2533,0.7001573139332167,0.8565131143927706,0.3053043009036308,['CDIPT'],0.9992483013234335,0,0,1
251,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7001573139332167,0.8565131143927706,0.3053043009036308,['BAX'],0.9992483013234335,0,0,1
252,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.7001573139332167,0.8565131143927706,0.3053043009036308,['IKBKG'],0.9992483013234335,0,0,1
253,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7001573139332167,0.8565131143927706,0.3053043009036308,['CALM2'],0.9992483013234335,0,0,1
254,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.7001573139332167,0.8565131143927706,0.3053043009036308,['CCND1'],0.9992483013234335,0,0,1
255,NRF2 pathway WP2884,0.7007606447142938,0.8558245976672081,0.3043217260736221,"['FTH1', 'MGST3', 'PRDX1', 'TXN', 'SQSTM1', 'FTL']",0.9992483013234335,0,0,6
256,One-carbon metabolism and related pathways WP3940,0.7026286729861448,0.824587493803555,0.29101896791372045,"['GPX4', 'SOD1']",0.9992483013234335,0,0,2
257,Calcium Regulation in the Cardiac Cell WP536,0.717332958332991,0.8463120745102953,0.28115770897756376,"['RGS4', 'GNG3', 'YWHAQ', 'PRKAR1A', 'CALM3', 'CALM2', 'YWHAH']",0.9992483013234335,0,0,7
258,Ebstein-Barr virus LMP1 signaling WP262,0.7248903897071095,0.795265384090599,0.2558645669269089,['IKBKG'],0.9992483013234335,0,0,1
259,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7248903897071095,0.795265384090599,0.2558645669269089,['CCND1'],0.9992483013234335,0,0,1
260,Pregnane X receptor pathway WP2876,0.7248903897071095,0.795265384090599,0.2558645669269089,['PSMC5'],0.9992483013234335,0,0,1
261,TLR4 Signaling and Tolerance WP3851,0.7248903897071095,0.795265384090599,0.2558645669269089,['IKBKG'],0.9992483013234335,0,0,1
262,Vitamin D in inflammatory diseases WP4482,0.7248903897071095,0.795265384090599,0.2558645669269089,['IKBKG'],0.9992483013234335,0,0,1
263,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7274462178713565,0.8091954022988506,0.2574982848685823,"['POMC', 'BAD', 'RPS6', 'HRAS']",0.9992483013234335,0,0,4
264,Oncostatin M Signaling Pathway WP2374,0.7287279751542017,0.7948735475051264,0.2515415213204665,"['RPS6', 'KRAS', 'HRAS']",0.9992483013234335,0,0,3
265,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.7475850861026464,0.742184017828717,0.2159066393563402,['RPS6'],0.9992483013234335,0,0,1
266,Imatinib and Chronic Myeloid Leukemia WP3640,0.7475850861026464,0.742184017828717,0.2159066393563402,['GADD45A'],0.9992483013234335,0,0,1
267,miRNAs involvement in the immune response in sepsis WP4329,0.7475850861026464,0.742184017828717,0.2159066393563402,['IKBKG'],0.9992483013234335,0,0,1
268,NRF2-ARE regulation WP4357,0.7475850861026464,0.742184017828717,0.2159066393563402,['RBX1'],0.9992483013234335,0,0,1
269,PDGFR-beta pathway WP3972,0.7475850861026464,0.742184017828717,0.2159066393563402,['HRAS'],0.9992483013234335,0,0,1
270,Urea cycle and associated pathways WP4595,0.7475850861026464,0.742184017828717,0.2159066393563402,['GOT1'],0.9992483013234335,0,0,1
271,Urea cycle and metabolism of amino groups WP497,0.7475850861026464,0.742184017828717,0.2159066393563402,['ODC1'],0.9992483013234335,0,0,1
272,Thermogenesis WP4321,0.7513524494430066,0.780668145459434,0.22317774547020247,"['RPS6', 'KRAS', 'HRAS', 'ACTG1']",0.9992483013234335,0,0,4
273,Interleukin-11 Signaling Pathway WP2332,0.7531705670803549,0.7419375398342893,0.21031225643277662,"['RPS6', 'HRAS']",0.9992483013234335,0,0,2
274,Integrated Cancer Pathway WP1971,0.7682917197951941,0.7179423919077284,0.18923940139829268,"['BAD', 'BAX']",0.9992483013234335,0,0,2
275,Physiological and pathological hypertrophy of the heart WP1528,0.7684092488978225,0.6957378223495702,0.18328017067349545,['CALM2'],0.9992483013234335,0,0,1
276,White fat cell differentiation WP4149,0.7684092488978225,0.6957378223495702,0.18328017067349545,['DDIT3'],0.9992483013234335,0,0,1
277,Spinal Cord Injury WP2431,0.771154039570484,0.7722781506338553,0.20068970923464097,"['BCAN', 'GAP43', 'CCND1', 'GADD45A', 'APEX1']",0.9992483013234335,0,0,5
278,Metapathway biotransformation Phase I and II WP702,0.7799934623819764,0.7756773646386644,0.19273235381003573,"['AKR7A2', 'AKR7A3', 'GPX4', 'GSTO1', 'MGST3', 'SULT4A1']",0.9992483013234335,0,0,6
279,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7825996587713343,0.6954469407265774,0.1704776940018979,"['KRAS', 'HRAS']",0.9992483013234335,0,0,2
280,MTHFR deficiency WP4288,0.7875169150875176,0.6547558851620877,0.15640181920304858,['CYCS'],0.9992483013234335,0,0,1
281,Trans-sulfuration and one-carbon metabolism WP2525,0.7875169150875176,0.6547558851620877,0.15640181920304858,['AHCY'],0.9992483013234335,0,0,1
282,Notch Signaling WP268,0.7961255905938119,0.674314850223072,0.1537426587034812,"['NOTCH4', 'DLL3']",0.9992483013234335,0,0,2
283,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7971027863763184,0.7579174664107485,0.1718741882919522,"['NOTCH4', 'STRAP', 'KRAS', 'HRAS', 'MEF2D', 'DLL3']",0.9992483013234335,0,0,6
284,Fragile X Syndrome  WP4549,0.799208546685053,0.7411952700543305,0.1661265845549907,"['PRKAR1A', 'CLTC', 'AP2S1', 'KRAS', 'AP2M1']",0.9992483013234335,0,0,5
285,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.8050494479701346,0.6183274965509923,0.13408529297701155,['H3F3B'],0.9992483013234335,0,0,1
286,Estrogen signaling pathway WP712,0.8050494479701346,0.6183274965509923,0.13408529297701155,['IKBKG'],0.9992483013234335,0,0,1
287,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8050494479701346,0.6183274965509923,0.13408529297701155,['IKBKG'],0.9992483013234335,0,0,1
288,One-carbon metabolism WP241,0.8050494479701346,0.6183274965509923,0.13408529297701155,['AHCY'],0.9992483013234335,0,0,1
289,Oxidative Stress WP408,0.8050494479701346,0.6183274965509923,0.13408529297701155,['SOD1'],0.9992483013234335,0,0,1
290,Toll-like Receptor Signaling related to MyD88 WP3858,0.8050494479701346,0.6183274965509923,0.13408529297701155,['IKBKG'],0.9992483013234335,0,0,1
291,Tumor suppressor activity of SMARCB1 WP4204,0.8050494479701346,0.6183274965509923,0.13408529297701155,['H3F3B'],0.9992483013234335,0,0,1
292,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8050494479701346,0.6183274965509923,0.13408529297701155,['PPIB'],0.9992483013234335,0,0,1
293,Type II interferon signaling (IFNG) WP619,0.8050494479701346,0.6183274965509923,0.13408529297701155,['HLA-B'],0.9992483013234335,0,0,1
294,EGF/EGFR signaling pathway WP437,0.8117831426379967,0.7552111020956325,0.1574781597949094,"['NDUFA13', 'AP2S1', 'NEDD8', 'KRAS', 'HRAS', 'MEF2D', 'AP2M1']",0.9992483013234335,0,0,7
295,IL-1 signaling pathway WP195,0.8209578975939572,0.6356733133023764,0.1254078260397216,"['IKBKG', 'SQSTM1']",0.9992483013234335,0,0,2
296,Interferon type I signaling pathways WP585,0.8209578975939572,0.6356733133023764,0.1254078260397216,"['RPS6', 'RACK1']",0.9992483013234335,0,0,2
297,Ethanol effects on histone modifications WP3996,0.8211365791219397,0.5857336751621173,0.11542809070813403,['AHCY'],0.9992483013234335,0,0,1
298,Fluoropyrimidine Activity WP1601,0.8211365791219397,0.5857336751621173,0.11542809070813403,['GGH'],0.9992483013234335,0,0,1
299,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8211365791219397,0.5857336751621173,0.11542809070813403,['GABRB3'],0.9992483013234335,0,0,1
300,Resistin as a regulator of inflammation WP4481,0.8211365791219397,0.5857336751621173,0.11542809070813403,['IKBKG'],0.9992483013234335,0,0,1
301,Integrin-mediated Cell Adhesion WP185,0.831031364992334,0.6841143530798703,0.12662118031070907,"['RAC3', 'ITGAE', 'HRAS', 'PAK4']",0.9992483013234335,0,0,4
302,Heart Development WP1591,0.8358973642425153,0.5563992359121299,0.09973425338946382,['VEGFB'],0.9992483013234335,0,0,1
303,The influence of laminopathies on Wnt signaling WP4844,0.8358973642425153,0.5563992359121299,0.09973425338946382,['CCND1'],0.9992483013234335,0,0,1
304,Glioblastoma signaling pathways WP2261,0.8423937483247176,0.6414611704085388,0.11001555528612238,"['CCND1', 'KRAS', 'HRAS']",0.9992483013234335,0,0,3
305,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8430412956336637,0.6012092398325668,0.1026500662036382,"['NABP2', 'BAX']",0.9992483013234335,0,0,2
306,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8494410615865282,0.5298585527811889,0.08646058091812357,['IKBKG'],0.9992483013234335,0,0,1
307,IL17 signaling pathway WP2112,0.8494410615865282,0.5298585527811889,0.08646058091812357,['IKBKG'],0.9992483013234335,0,0,1
308,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8494410615865282,0.5298585527811889,0.08646058091812357,['YWHAQ'],0.9992483013234335,0,0,1
309,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8494410615865282,0.5298585527811889,0.08646058091812357,['HRAS'],0.9992483013234335,0,0,1
310,Vitamin D-sensitive calcium signaling in depression WP4698,0.8494410615865282,0.5298585527811889,0.08646058091812357,['GPX4'],0.9992483013234335,0,0,1
311,Zinc homeostasis WP3529,0.8494410615865282,0.5298585527811889,0.08646058091812357,['MT3'],0.9992483013234335,0,0,1
312,Phosphodiesterases in neuronal function WP4222,0.8531299291670368,0.5853376270504176,0.0929770322020001,"['PDE1C', 'PDE6G']",0.9992483013234335,0,0,2
313,Corticotropin-releasing hormone signaling pathway WP2355,0.8593993116960414,0.6175970228601807,0.09357929434179972,"['POMC', 'STAR', 'CRH']",0.9992483013234335,0,0,3
314,Prolactin Signaling Pathway WP2037,0.8593993116960414,0.6175970228601807,0.09357929434179972,"['RPS6', 'PPIB', 'HRAS']",0.9992483013234335,0,0,3
315,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8618679366365326,0.505730659025788,0.0751784938570858,['DDIT3'],0.9992483013234335,0,0,1
316,Target Of Rapamycin (TOR) Signaling WP1471,0.8618679366365326,0.505730659025788,0.0751784938570858,['IDI1'],0.9992483013234335,0,0,1
317,RANKL/RANK signaling pathway WP2018,0.8626236044357846,0.5702799431288915,0.08427416269500537,"['IKBKG', 'SQSTM1']",0.9992483013234335,0,0,2
318,Cardiac Hypertrophic Response WP2795,0.8715517609614144,0.5559751434034417,0.07643547540771436,"['IKBKG', 'CALM2']",0.9992483013234335,0,0,2
319,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8732700026496507,0.483700842988248,0.0655465380409544,['CCND1'],0.9992483013234335,0,0,1
320,Melatonin metabolism and effects WP3298,0.8732700026496507,0.483700842988248,0.0655465380409544,['CALM2'],0.9992483013234335,0,0,1
321,Neural Crest Cell Migration during Development WP4564,0.8732700026496507,0.483700842988248,0.0655465380409544,['PAK4'],0.9992483013234335,0,0,1
322,Complement system WP2806,0.8747741508108426,0.5954374572795625,0.07966330309172111,"['RPS19', 'CD59', 'TXN']",0.9992483013234335,0,0,3
323,Mesodermal commitment pathway WP2857,0.8794428873938036,0.645778055252068,0.08296094630663552,"['TRIM71', 'CCND1', 'PRKAR1A', 'NABP2', 'RPL38']",0.9992483013234335,0,0,5
324,Circadian rhythm related genes WP3594,0.8798192801913526,0.6816910190943256,0.08728287007399603,"['AHCY', 'STAR', 'CAVIN3', 'CRH', 'RPS27A', 'UBA52', 'SKP1']",0.9992483013234335,0,0,7
325,Nuclear Receptors Meta-Pathway WP2882,0.8811330599310353,0.7262995362079258,0.0919107598480415,"['PSMC5', 'CCND1', 'FTH1', 'MGST3', 'PRDX1', 'AIP', 'BAX', 'DBI', 'TXN', 'SQSTM1', 'FTL']",0.9992483013234335,0,0,11
326,Cardiac Progenitor Differentiation WP2406,0.8837316982558552,0.46350684495383637,0.057290266987077246,['MESP1'],0.9992483013234335,0,0,1
327,Microglia Pathogen Phagocytosis Pathway WP3937,0.8837316982558552,0.46350684495383637,0.057290266987077246,['RAC3'],0.9992483013234335,0,0,1
328,Pre-implantation embryo WP3527,0.8837316982558552,0.46350684495383637,0.057290266987077246,['DDIT3'],0.9992483013234335,0,0,1
329,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8837316982558552,0.46350684495383637,0.057290266987077246,['BAX'],0.9992483013234335,0,0,1
330,Insulin Signaling WP481,0.8843071557691423,0.659622584139412,0.08110113458798567,"['CAP1', 'XBP1', 'STX4', 'HRAS', 'PFKM', 'VAMP2']",0.9992483013234335,0,0,6
331,Focal Adhesion WP306,0.8862637533268434,0.6882528324388789,0.08310011685390802,"['CCND1', 'BAD', 'VEGFB', 'RAC3', 'HRAS', 'MYL12B', 'PAK4', 'ACTG1']",0.9992483013234335,0,0,8
332,AGE/RAGE pathway WP2324,0.8878251729796806,0.5294090867704634,0.06298932219171977,"['CYCS', 'SOD1']",0.9992483013234335,0,0,2
333,Adipogenesis WP236,0.8882298086652245,0.6087230357424027,0.07214876141438362,"['GADD45A', 'DDIT3', 'GTF3A', 'MEF2D']",0.9992483013234335,0,0,4
334,Alpha 6 Beta 4 signaling pathway WP244,0.8933305111905505,0.4449283667621777,0.05018732057034306,['HRAS'],0.9992483013234335,0,0,1
335,Neovascularisation processes WP4331,0.8933305111905505,0.4449283667621777,0.05018732057034306,['NOTCH4'],0.9992483013234335,0,0,1
336,Neural Crest Cell Migration in Cancer WP4565,0.8933305111905505,0.4449283667621777,0.05018732057034306,['PAK4'],0.9992483013234335,0,0,1
337,Hedgehog Signaling Pathway WP4249,0.9021375495946309,0.4277790022775696,0.0440562221837939,['CCND1'],0.9992483013234335,0,0,1
338,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9021375495946309,0.4277790022775696,0.0440562221837939,['SUPT4H1'],0.9992483013234335,0,0,1
339,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9021684465978868,0.5052581261950286,0.052018359505699274,"['HMGCS1', 'CALM2']",0.9992483013234335,0,0,2
340,Endochondral Ossification WP474,0.9021684465978868,0.5052581261950286,0.052018359505699274,"['HMGCS1', 'CALM2']",0.9992483013234335,0,0,2
341,Ebola Virus Pathway on Host WP4217,0.9098922795241806,0.5769020251778872,0.05447631631151523,"['CLTC', 'HLA-B', 'EIF2S1', 'ACTG1']",0.9992483013234335,0,0,4
342,Energy Metabolism WP1541,0.9102180668833475,0.4118999610881177,0.0387478718194359,['MEF2D'],0.9992483013234335,0,0,1
343,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9102180668833475,0.4118999610881177,0.0387478718194359,['MAP1LC3A'],0.9992483013234335,0,0,1
344,Prostaglandin Synthesis and Regulation WP98,0.9102180668833475,0.4118999610881177,0.0387478718194359,['S100A6'],0.9992483013234335,0,0,1
345,B Cell Receptor Signaling Pathway WP23,0.912316703764725,0.5375366568914957,0.0493287103134921,"['IKBKG', 'HRAS', 'MEF2D']",0.9992483013234335,0,0,3
346,IL-6 signaling pathway WP364,0.9176319434761226,0.3971551371264838,0.03413901942738349,['BAD'],0.9992483013234335,0,0,1
347,Chemokine signaling pathway WP3929,0.9192563648720017,0.5621999127018769,0.0473317426779844,"['GNG3', 'KRAS', 'IKBKG', 'HRAS']",0.9992483013234335,0,0,4
348,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9305912384904013,0.5720018582400095,0.041147042058131265,"['YWHAQ', 'PRKAR1A', 'SLC25A4', 'VAMP2', 'YWHAH']",0.9992483013234335,0,0,5
349,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9306750465125876,0.3706144539955428,0.026626832388707253,['CCND1'],0.9992483013234335,0,0,1
350,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.9306750465125876,0.3706144539955428,0.026626832388707253,['RPS6'],0.9992483013234335,0,0,1
351,Vitamin B12 metabolism WP1533,0.9306750465125876,0.3706144539955428,0.026626832388707253,['SOD1'],0.9992483013234335,0,0,1
352,ATM Signaling Network in Development and Disease  WP3878,0.9364009679175648,0.35862833903318236,0.023566009581830805,['IKBKG'],0.9992483013234335,0,0,1
353,Development of ureteric collection system WP5053,0.9364009679175648,0.35862833903318236,0.023566009581830805,['CCND1'],0.9992483013234335,0,0,1
354,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9364009679175648,0.35862833903318236,0.023566009581830805,['NUP98'],0.9992483013234335,0,0,1
355,Endoderm differentiation WP2853,0.938961921950019,0.5285075716110199,0.033285593053298965,"['TRIM71', 'TCEAL2', 'NABP2', 'NME1']",0.9992483013234335,0,0,4
356,T-cell receptor (TCR) signaling pathway WP69,0.9399574830679689,0.4356465339481873,0.026975510244064,"['IKBKG', 'HRAS']",0.9992483013234335,0,0,2
357,DNA IR-damage and cellular response via ATR WP4016,0.9440619388637895,0.4272319458743933,0.024592966879343377,"['RPA2', 'IKBKG']",0.9992483013234335,0,0,2
358,Netrin-UNC5B signaling pathway WP4747,0.9464741630362661,0.3368354027379815,0.018529856488728118,['DAPK1'],0.9992483013234335,0,0,1
359,Phosphoinositides metabolism WP4971,0.9464741630362661,0.3368354027379815,0.018529856488728118,['PIP4P1'],0.9992483013234335,0,0,1
360,TGF-beta Receptor Signaling WP560,0.9464741630362661,0.3368354027379815,0.018529856488728118,['HRAS'],0.9992483013234335,0,0,1
361,Vitamin D Receptor Pathway WP2877,0.9485760811065953,0.5101510547408288,0.026932547882302912,"['CDKN2D', 'CCND1', 'GADD45A', 'S100A6']",0.9992483013234335,0,0,4
362,IL-4 signaling pathway WP395,0.950896151309669,0.32690038766222823,0.01645957242613906,['BAD'],0.9992483013234335,0,0,1
363,Complement and Coagulation Cascades WP558,0.9549531244665147,0.3175330877336608,0.014636060244605413,['CLTC'],0.9992483013234335,0,0,1
364,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9549531244665147,0.3175330877336608,0.014636060244605413,['RPS6'],0.9992483013234335,0,0,1
365,Wnt Signaling Pathway WP363,0.9549531244665147,0.3175330877336608,0.014636060244605413,['CCND1'],0.9992483013234335,0,0,1
366,Regulation of toll-like receptor signaling pathway WP1449,0.9557296409021565,0.4561053942452645,0.02065254727208053,"['CUEDC2', 'IKBKG', 'SQSTM1']",0.9992483013234335,0,0,3
367,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9579584733565,0.39657880360557224,0.017033396380787286,"['IKBKG', 'CALM2']",0.9992483013234335,0,0,2
368,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9586751862364872,0.30868619335668046,0.013027471673954552,['HRAS'],0.9992483013234335,0,0,1
369,Allograft Rejection WP2328,0.9652227924150085,0.292389282662243,0.010349507923907932,['HLA-B'],0.9992483013234335,0,0,1
370,Neural Crest Differentiation WP2064,0.9707215525506132,0.36391561922076293,0.01081397658207586,"['NOTCH4', 'DLL3']",0.9992483013234335,0,0,2
371,3q29 copy number variation syndrome WP4906,0.9707337488479516,0.2777220630372493,0.008249192694300491,['DYNLL1'],0.9992483013234335,0,0,1
372,Pathways affected in adenoid cystic carcinoma WP3651,0.9731527958079237,0.27092505882078877,0.007373001515917204,['HRAS'],0.9992483013234335,0,0,1
373,MECP2 and Associated Rett Syndrome WP3584,0.9753720503758067,0.26445172147177876,0.006594444987464877,['RPS6'],0.9992483013234335,0,0,1
374,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9809892410851799,0.2467579327178181,0.0047362191444682376,['CCND1'],0.9992483013234335,0,0,1
375,Genes related to primary cilium development (based on CRISPR) WP4536,0.9811501899287695,0.3311549327930139,0.006301789730517145,"['TRAF3IP1', 'DYNLL1']",0.9992483013234335,0,0,2
376,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9823428151222527,0.5378040215383815,0.009580942420463595,"['GNG3', 'RAB14', 'BAD', 'RPS6', 'VEGFB', 'KRAS', 'IKBKG', 'ITGAE', 'HRAS']",0.9992483013234335,0,0,9
377,AMP-activated protein kinase (AMPK) signaling WP1403,0.9825611497216667,0.24137286657530835,0.004246400012953576,['CCNB1'],0.9992483013234335,0,0,1
378,Ectoderm Differentiation WP2858,0.9834102410861848,0.3778708133971292,0.006321366866975241,"['KCNK10', 'CELSR2', 'LY6E']",0.9992483013234335,0,0,3
379,Osteoblast differentiation WP4787,0.9859918544457503,0.3123905959658525,0.004406952124742236,"['NOTCH4', 'DLL3']",0.9992483013234335,0,0,2
380,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9876528732688669,0.22198662846227316,0.002757958723113594,['CCND1'],0.9992483013234335,0,0,1
381,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9876528732688669,0.22198662846227316,0.002757958723113594,['YWHAQ'],0.9992483013234335,0,0,1
382,MAPK Signaling Pathway WP382,0.9877242087821269,0.4807250553397653,0.005937801043207394,"['RRAS', 'GADD45A', 'DDIT3', 'RAC3', 'KRAS', 'IKBKG', 'HRAS']",0.9992483013234335,0,0,7
383,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9896109604492742,0.21341194621996915,0.0022287425480164,['ACTG1'],0.9992483013234335,0,0,1
384,Toll-like Receptor Signaling Pathway WP75,0.9896109604492742,0.21341194621996915,0.0022287425480164,['IKBKG'],0.9992483013234335,0,0,1
385,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9910648693363249,0.2878994810161158,0.0025839808527451623,"['CAP1', 'HRAS']",0.9992483013234335,0,0,2
386,PI3K-Akt signaling pathway WP4172,0.991170446179879,0.49935916347860576,0.00442869922849731,"['GNG3', 'CCND1', 'BAD', 'RPS6', 'VEGFB', 'COL9A3', 'KRAS', 'IKBKG', 'HRAS']",0.9992483013234335,0,0,9
387,"GPCRs, Other WP117",0.9912587019756277,0.2054724256252432,0.0018039918608727416,['CELSR2'],0.9992483013234335,0,0,1
388,Joubert Syndrome WP4656,0.9943239938759232,0.18797856668771146,0.0010700070599147593,['PDE6G'],0.9992483013234335,0,0,1
389,Wnt signaling pathway and pluripotency WP399,0.9952245054643782,0.18178401991638873,0.0008701880405962913,['CCND1'],0.9992483013234335,0,0,1
390,"GPCRs, Class A Rhodopsin-like WP455",0.9960893661383033,0.3045169219964005,0.0011931887724332343,"['MAS1', 'GPR22', 'APLNR']",0.9992483013234335,0,0,3
391,Pathways Regulating Hippo Signaling WP4540,0.9968994385901313,0.1679401464501751,0.0005215176544570873,['PRKAR1A'],0.9992483013234335,0,0,1
392,Wnt signaling WP428,0.9968994385901313,0.1679401464501751,0.0005215176544570873,['CCND1'],0.9992483013234335,0,0,1
393,ESC Pluripotency Pathways WP3931,0.9981534954124301,0.15386554175952458,0.00028437606045290476,['HRAS'],0.9992483013234335,0,0,1
394,Ciliopathies WP4803,0.9992483013234335,0.25095693779904304,0.00018871493529175782,"['TRAF3IP1', 'NEK2', 'CCNQ']",0.9992483013234335,0,0,3
